Decrease in Chitinase 3-Like Protein 1 Levels Reflects Improvement in Liver Fibrosis after HCV Eradication

<div>The dynamic changes of serum CHI3L1 of DAA-treated patients and PR-experienced patients in different subgroups. T0: at the baseline; T1: at the end of treatment; T2: at 24 weeks after treatment; T3: at 48 weeks after treatment.</div>

Disease Markers

fig5

Figure 5

Figure 5: Decrease in Chitinase 3-Like Protein 1 Levels Reflects Improvement in Liver Fibrosis after HCV Eradication 